
About Cytocom
Cytocom is a Healthcare company based in Winter Park (United States) founded in 2013. Cytocom has completed 1 acquisition, including ImQuest Life Sciences. Cytocom offers products and services including Blog Platform. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Viral. Its legal entity is Cytocom, Inc. Similar companies include Biogen, Moderna and Adaptive Biotechnologies; 3 of its 3 listed similar companies have raised funding.
Company details
Developer of therapeutic solutions for the treatment of infectious diseases. The drug pipeline includes CYTO-201 that helps in the treatment of a variety of viruses, CYTO-201 and CYTO-401 for the treatment of HIV and decreases the replication of the H1N1 influenza virus. Its products help in treating multiple diseases such as autoimmune diseases, infectious diseases, inflammatory diseases, cancers, and many more. It has developed CYTO-201 Lotrexon that helps to treat neurological disorders.
- Headquarters Winter Park, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website cytocom.com
- Social X
- Legal Name Cytocom, Inc
- Latest Funding Round$2.28M (USD), Debt – Conventional
Jul 2020
- Investments & Acquisitions
Products & Services of Cytocom
Cytocom offers a comprehensive portfolio of products and services, including Blog Platform.
Site for accessing articles on diverse topics
Funding Insights of Cytocom
- Total Rounds 1
- Last Round Debt – Conventional β $2.28M
- First Round $2.28M
(Jul 2020)
All 1 funding rounds of Cytocom with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $2.28M | Debt – Conventional | β | β | β |
People of Cytocom
8 people are tracked at Cytocom (4 in leadership, 4 in board & advisors).
| Name | Role | Group |
|---|---|---|
Allie Lopez | Senior Director of Clinical Operations | Leadership |
Peter Aronstam | Chief Financial Officer | Leadership |
Taunia Markvicka | Chief Operations Officer | Leadership |
Kelly Wilson | Global Director of Program & Project Management | Leadership |
Fengping Shan | Scientific Advisor | Board & advisors |
Lea Verny | Director | Board & advisors |
Randy Saluck | Director | Board & advisors |
Steve Barbarick | Director | Board & advisors |
Complete people profiles for Cytocom
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytocom
Cytocom has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ImQuest Life Sciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
First-in-class drugs for infectious disease, cancer, and inflammation are developed. | imquestls.com | Frederick, United States | 2005 | Jul 2020 | β’β’β’β’ |
Complete acquisition details for Cytocom
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cytocom
3 dated milestones of Cytocom across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Cytocom is founded.
- Funding First funding round of $2.3M.
- Acquisition Acquires ImQuest Life Sciences.
Similar companies to Cytocom
Cytocom has 3 listed similar companies in our database, 3 of them funded. They include Biogen, Moderna and Adaptive Biotechnologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. | |
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| adaptivebiotech.com | 2009 | Seattle, United States | $419.15M | 609 | Clinical diagnostics and drug discovery for immune diseases are provided. |
Detailed similar companies of Cytocom
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cytocom
Websites that share an audience with Cytocom (cytocom.com).
Websites whose visitors overlap most with Cytocom. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
easybib.co.uk | easybib.co.uk | 100% | #1,818,141 | β | |
businesstalking.co.uk | businesstalking.co.uk | 87% | β | ||
glowmagazine.co.uk | glowmagazine.co.uk | 78% | β | ||
thegloworm.com | thegloworm.com | 78% | β | ||
| hittechmarket.com | 64% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 21 similar websites and full traffic analytics for Cytocom
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Cytocom (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 87.11 M | 4,647 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytocom
Complete news archive for Cytocom
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytocom
Cytocom was founded in 2013 and raised its 1st funding round 7 years after it was founded.
Cytocom is headquartered in Winter Park, United States. It is registered at Winter Park, Florida, United States.
Developer of therapeutic solutions for the treatment of infectious diseases. The drug pipeline includes CYTO-201 that helps in the treatment of a variety of viruses, CYTO-201 and CYTO-401 for the treatment of HIV and decreases the replication of the H1N1 influenza virus. Its products help in treating multiple diseases such as autoimmune diseases, infectious diseases, inflammatory diseases, cancers, and many more. It has developed CYTO-201 Lotrexon that helps to treat neurological disorders.
Cytocom's top competitors include Moderna, Adaptive Biotechnologies and Biogen.
Cytocom offers Blog Platform.
Cytocom has made 1 acquisition, including ImQuest Life Sciences.
Cytocom operates through Cytocom, Inc.
